Search Videos and More
News
Nanoparticles developed at UTSW effectively fight tumors
Activating a specific pathway in a subset of immune cells eradicates immunologically ‘cold’ tumors, UTSW study shows
News
How Glen’s journey to getting a power wheelchair got much smoother
Glen Denehie is a substitute teacher, soccer fanatic, home cook, and dad of two busy teens. He also has facioscapulohumeral muscular dystrophy (FSHD), one of 30 forms of muscular dystrophy.
News
Ethnic minorities face higher risk of liver transplant failure
UTSW study of patients with alcohol-associated diseases could lead to interventions that improve outcomes of these procedures
News
Lung cancer treatment shows promise in tumor models
UT Southwestern study uses 6-thio-dG molecule to damage DNA and halt spread of small cell lung cancer
News
Why Cancer Care Specialization Matters: The Story of a CLL Survivor
After undergoing a routine physical in September 2015, William Marks was diagnosed with chronic lymphocytic leukemia (CLL). Following an initial consultation with an oncologist, Mr. Marks left feeling more bewildered and distressed than when he first received his diagnosis.
News
UTSW Simmons Cancer Center Welcomes New Deputy Director for Clinical Affairs
UT Southwestern welcomes Jason B. Fleming, M.D., FACS, as Deputy Director for Clinical Affairs of the Harold C. Simmons Comprehensive Cancer Center. An internationally recognized surgical oncologist specializing in the treatment of pancreatic cancer, Dr. Fleming rejoins UT Southwestern from the Moffitt Cancer Center in Tampa, Fla., where he was Chair of Gastrointestinal Oncology.
News
DBS: A New Tool Against Schizophrenia and Depression
Scientists in the Neurological Surgery and Psychiatry Departments at UT Southwestern Medical Center are engaged in three separate clinical trials to test the efficacy of deep brain stimulation against depression and schizophrenia.
News
Simmons Cancer Center awarded nearly $19 million in CPRIT funding
The Cancer Prevention and Research Institute of Texas (CPRIT) awarded nearly $13 million in grants to scientists and physicians at UT Southwestern this year for academic research and prevention efforts, plus $6 million for recruitment.
Course
2024 Oncology Year in Review
This program will provide participants with the latest information available as presented at the 2024 American Society of Clinical Oncology (ASCO) meeting, 2024 European Society for Medical Oncology (ESMO) meeting, and major findings from other meetings that took place in 2024. Oncology/Hematology faculty members from UT Southwestern Medical Center will provide participants with analysis of the more clinically applicable presentations from this year's national conferences via disease-specific didactic talks and panel discussions.
News
How an experimental drug reverses fatty liver disease
Promising treatment in clinical trials has double action against triglyceride and fatty acid synthesis, UTSW study shows
News
Age, sex, race among top risk factors for revision knee surgery
UTSW researchers say information may help advise patients on expectations after initial procedure
News
UT Southwestern recognized nationally for excellence in MSA patient care
Every year in the U.S., about 10,000 people are diagnosed with a neurological disorder that most have never heard of: multiple system atrophy (MSA).